Shares in German chemicals and pharmaceuticals giant Bayer plunged as markets opened Wednesday, after a second US jury ruled that blockbuster pesticide Roundup—made by recently-acquired Monsanto—causes cancer.
Shares in German chemicals and pharmaceuticals giant Bayer plunged as markets opened Wednesday, after a second US jury ruled that blockbuster pesticide Roundup—made by recently-acquired Monsanto—causes cancer.